Počet záznamů: 1  

Rational design of urea-based glutamate carboxypeptidase II (GCPII) inhibitors as versatile tools for specific drug targeting and delivery

  1. 1.
    SYSNO ASEP0431499
    Druh ASEPJ - Článek v odborném periodiku
    Zařazení RIVJ - Článek v odborném periodiku
    Poddruh JČlánek ve WOS
    NázevRational design of urea-based glutamate carboxypeptidase II (GCPII) inhibitors as versatile tools for specific drug targeting and delivery
    Tvůrce(i) Tykvart, Jan (UOCHB-X) RID, ORCID
    Schimer, Jiří (UOCHB-X) RID, ORCID
    Bařinková, Jitka (UOCHB-X)
    Pachl, Petr (UOCHB-X) RID, ORCID
    Poštová Slavětínská, Lenka (UOCHB-X) RID
    Majer, Pavel (UOCHB-X)
    Konvalinka, Jan (UOCHB-X) RID, ORCID
    Šácha, Pavel (UOCHB-X) RID, ORCID
    Celkový počet autorů8
    Zdroj.dok.Bioorganic & Medicinal Chemistry. - : Elsevier - ISSN 0968-0896
    Roč. 22, č. 15 (2014), s. 4099-4108
    Poč.str.10 s.
    Jazyk dok.eng - angličtina
    Země vyd.GB - Velká Británie
    Klíč. slovaGCPII ; PSMA ; structure-aided drug design ; specific drug targeting
    Vědní obor RIVCE - Biochemie
    CEPGBP208/12/G016 GA ČR - Grantová agentura ČR
    Institucionální podporaUOCHB-X - RVO:61388963
    UT WOS000339859700034
    EID SCOPUS84905081813
    DOI10.1016/j.bmc.2014.05.061
    AnotaceGlutamate carboxypeptidase II (GCPII), also known as prostate specific membrane antigen (PSMA), is an established prostate cancer marker and is considered a promising target for specific anticancer drug delivery. Low-molecular-weight inhibitors of GCPII are advantageous specific ligands for this purpose. However, they must be modified with a linker to enable connection of the ligand with an imaging molecule, anticancer drug, and/or nanocarrier. Here, we describe a structure-activity relationship (SAR) study of GCPII inhibitors with linkers suitable for imaging and drug delivery. Structure-assisted inhibitor design and targeting of a specific GCPII exosite resulted in a 7-fold improvement in K-i value compared to the parent structure. X-ray structural analysis of the inhibitor series led to the identification of several inhibitor binding modes. We also optimized the length of the inhibitor linker for effective attachment to a biotin-binding molecule and showed that the optimized inhibitor could be used to target nanoparticles to cells expressing GCPII.
    PracovištěÚstav organické chemie a biochemie
    Kontaktasep@uochb.cas.cz ; Kateřina Šperková, Tel.: 232 002 584 ; Viktorie Chládková, Tel.: 232 002 434
    Rok sběru2015
Počet záznamů: 1  

  Tyto stránky využívají soubory cookies, které usnadňují jejich prohlížení. Další informace o tom jak používáme cookies.